Bionic Power, Vancouver, British Columbia, a provider of wearable medical technology, has secured roughly $5 million (CAD) in funding. The investment will support Bionic Power’s expanded market presence and advance the commercialization of its lower-body smart orthotic devices, designed to improve personal mobility and walking abilities in children and adults with neuromuscular diseases and conditions.
The Series A Investment Round began in July with an initial investment from Hanger Ventures, that closed on July 16, and was recently followed by subsequent investments from Thuasne North America, and venture-capital firm, Viscogliosi Brothers Watermark Holdings, which closed on October 16.
“We are thrilled to advance our Series A Investment with such strong strategic partners and look forward to strengthening our relationship with Thuasne as we continue our commercial expansion and product development efforts,” said Gualtiero Guadagni, president and CEO of Bionic Power. “Investment in Bionic Power by organizations like Thuasne and Hanger validates and supports our product and business case and reinforces the company’s commitment to improving mobility for those who need it most.”
“As one of the composite orthotics global leaders, Thuasne is thrilled to put its expertise at the service of such a promising project,” said Delphine Hanton, Thuasne Group CEO.
Read the announcement.
